Fairtility Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Fairtility Ltd - overview
Established
2019
Location
Tel Aviv, -, Israel
Primary Industry
Software
About
Founded in 2019 by CEO Eran Eshed, and based in Tel Aviv, Israel, Fairtility Ltd is a developer of in vitro fertilization (IVF) solutions using AI. In May 2022, Fairtility Ltd raised USD 15 million in series A funding led by new investor Gurnet Point Capital, along with investor Nacre Capital. Fairtility Ltd provides CHLOE EQ™ (Cultivating Human Life through Optimal Embryos), which is an Embryo Quality Assessment Assistant that provides In vitro fertilization (IVF) solutions by analyzing the biological data of the system's embryo assessment and producing data-driven embryo quality assessment for pregnancy and less number of IVF cycles using artificial intelligence and big data. The company also develops KID+TM software that provides information related to predictions from fertilization time to the Blastocyst stage.
The company plans to use the funding to further develop its AI platform to improve IVF outcomes embryo quality assessment assistant CHLOE EQ™.
Current Investors
Gurnet Point Capital, Nacre Capital
Primary Industry
Software
Sub Industries
Diagnostic Equipment, Medical Software
Website
www.fairtility.com
Verticals
Artificial Intelligence, Big Data
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.